These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 37265795)

  • 1. The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity.
    Salemme V; Centonze G; Avalle L; Natalini D; Piccolantonio A; Arina P; Morellato A; Ala U; Taverna D; Turco E; Defilippi P
    Front Oncol; 2023; 13():1170264. PubMed ID: 37265795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer.
    Kudelova E; Smolar M; Holubekova V; Hornakova A; Dvorska D; Lucansky V; Koklesova L; Kudela E; Kubatka P
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor heterogeneity: preclinical models, emerging technologies, and future applications.
    Proietto M; Crippa M; Damiani C; Pasquale V; Sacco E; Vanoni M; Gilardi M
    Front Oncol; 2023; 13():1164535. PubMed ID: 37188201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recapitulating spatiotemporal tumor heterogeneity in vitro through engineered breast cancer microtissues.
    Mazio C; Casale C; Imparato G; Urciuolo F; Netti PA
    Acta Biomater; 2018 Jun; 73():236-249. PubMed ID: 29679778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models.
    Blanquart C; Jaurand MC; Jean D
    Front Oncol; 2020; 10():388. PubMed ID: 32269966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches.
    Xulu KR; Nweke EE; Augustine TN
    Front Genet; 2023; 14():1087432. PubMed ID: 37662839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity.
    Pan D; Jia D
    Front Mol Biosci; 2021; 8():757024. PubMed ID: 34722635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
    Janiszewska M; Stein S; Metzger Filho O; Eng J; Kingston NL; Harper NW; Rye IH; Alečković M; Trinh A; Murphy KC; Marangoni E; Cristea S; Oakes B; Winer EP; Krop IE; Russnes HG; Spellman PT; Bucher E; Hu Z; Chin K; Gray JW; Michor F; Polyak K
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33886505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies.
    Zhao N; Rosen JM
    Semin Cancer Biol; 2022 Jul; 82():3-10. PubMed ID: 34274486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cancer metabolism on therapy resistance - Clinical implications.
    Gonçalves AC; Richiardone E; Jorge J; Polónia B; Xavier CPR; Salaroglio IC; Riganti C; Vasconcelos MH; Corbet C; Sarmento-Ribeiro AB
    Drug Resist Updat; 2021 Dec; 59():100797. PubMed ID: 34955385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment.
    Wang YF; Yuan SX; Jiang H; Li ZX; Yin HZ; Tan J; Dai ZH; Ge CM; Sun SH; Yang F
    Theranostics; 2022; 12(9):4163-4180. PubMed ID: 35673582
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiplex Tissue Imaging: Spatial Revelations in the Tumor Microenvironment.
    van Dam S; Baars MJD; Vercoulen Y
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Cell Genomics for Tumor Heterogeneity.
    Lee HO; Park WY
    Adv Exp Med Biol; 2021; 1187():205-214. PubMed ID: 33983580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer.
    Wang L; Zhu B; Zhang M; Wang X
    Semin Cell Dev Biol; 2017 Apr; 64():90-97. PubMed ID: 27639893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor heterogeneity in muscle-invasive bladder cancer.
    Kang HW; Kim WJ; Choi W; Yun SJ
    Transl Androl Urol; 2020 Dec; 9(6):2866-2880. PubMed ID: 33457261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.